EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of TGFβ1 activation prevents radiation‐induced lung fibrosis

Minxiao Yi, Ye Yuan, Li Ma, Long Li, Wan Qin, Bili Wu, Bolong Zheng, Xin Liao, Guangyuan Hu, Bo Liu

Clinical and Translational Medicine · 2024-01 · 14 (1)

DOI: 10.1002/ctm2.1546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 18.01.2024. Verfasst von Minxiao Yi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Radiation Pneumonitis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Radiotherapy is the main treatment modality for thoracic tumours, but it may induce pulmonary fibrosis. Currently, the pathogenesis of radiation‐induced pulmonary fibrosis (RIPF) is unclear, and effective treatments are lacking. Transforming growth factor beta 1 (TGFβ1) plays a central role in RIPF. We found that activated TGFβ1 had better performance for radiation pneumonitis (RP) risk prediction by detecting activated and total TGFβ1 levels in patient serum. αv integrin plays key roles in TGFβ1 activation, but the role of αv integrin‐mediated TGFβ1 activation in RIPF is unclear. Here, we investigated the role of αv integrin‐mediated TGFβ1 activation in RIPF and the application of the integrin antagonist cilengitide to prevent RIPF.

Methods

Itgav loxP/loxP ;Pdgfrb‐Cre mice were generated by conditionally knocking out Itgav in myofibroblasts, and wild‐type mice were treated with cilengitide or placebo. All mice received 16 Gy of radiation or underwent a sham radiation procedure. Lung fibrosis was measured by a modified Ashcroft score and microcomputed tomography (CT). An enzyme‐linked immunosorbent assay (ELISA) was used to measure the serum TGFβ1 concentration, and total Smad2/3 and p‐Smad2/3 levels were determined via Western blotting.

Results

Conditional Itgav knockout significantly attenuated RIPF ( p < .01). Hounsfield units (HUs) in the lungs were reduced in the knockout mice compared with the control mice ( p < .001). Conditional Itgav knockout decreased active TGFβ1 secretion and inhibited fibroblast p‐Smad2/3 expression. Exogenous active TGFβ1, but not latent TGFβ1, reversed these reductions. Furthermore, cilengitide treatment elicited similar results and prevented RIPF.

Conclusions

The present study revealed that conditional Itgav knockout and cilengitide treatment both significantly attenuated RIPF in mice by inhibiting αv integrin‐mediated TGFβ1 activation. Highlights Activated TGFβ1 has a superior capacity in predicting radiation pneumonitis (RP) risk and plays a vital role in the development of radiation‐induced pulmonary fibrosis (RIPF). Conditional knock out Itgav in myofibroblasts prevented mice from developing RIPF. Cilengitide alleviated the development of RIPF by inhibiting αv integrin‐mediated TGFβ1 activation and may be used in targeted approaches for preventing RIPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisRadiation PneumonitisAnimalsHumansMiceIntegrin alphaVLungX-Ray MicrotomographyTransforming Growth Factor beta1

Stichwörter der Autor:innen

cilengitideradiation-induced pulmonary fibrosistransforming growth factor beta 1αv integrin

Substanzen

Integrin alphaVTgfb1 protein, mouseTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • School of Computer Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Integrative Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yi, M., Yuan, Y., Ma, L., Li, L., Qin, W., Wu, B., Zheng, B., Liao, X., Hu, G., & Liu, B. (2024). Inhibition of TGFβ1 activation prevents radiation‐induced lung fibrosis. Clinical and Translational Medicine, 14(1). https://doi.org/10.1002/ctm2.1546

Vancouver

Yi M, Yuan Y, Ma L, Li L, Qin W, Wu B, et al. Inhibition of TGFβ1 activation prevents radiation‐induced lung fibrosis. Clinical and Translational Medicine. 2024;14(1). doi:10.1002/ctm2.1546

BibTeX
@article{Yi2024,
  author = {Yi, Minxiao and Yuan, Ye and Ma, Li and Li, Long and Qin, Wan and Wu, Bili and Zheng, Bolong and Liao, Xin and Hu, Guangyuan and Liu, Bo},
  title = {Inhibition of TGFβ1 activation prevents radiation‐induced lung fibrosis},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  volume = {14},
  number = {1},
  doi = {10.1002/ctm2.1546}
}
Kostenlos starten →